IP Verse

Pharmaceutical Composition Comprising Lenvatinib Mesylate - EP3606511

PATENT ANALYSIS

Patent Details

Grant Date
Apr 20, 2022
Company
SYNTHON B.V.
Oppositions

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Synthon B.V.

EP3697392

EP3606511

EP3206666

Want to monitor this patent?

Feel free to send us a message here and we will get back to you